Linzagolix

CAT: 0931-MF-0006216-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0931-MF-0006216-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
935283-04-8
Target
GNRH Receptor
Related Pathways
GPCR/G Protein
Purity
0.9968
Bioactivity
Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis. As of December 2020, it is under review for approval for uterine fibroids, is in phase III clinical trials for endometriosis, and is in phase II clinical studies for adenomyosis.
Smiles
COc1cc(F)c(cc1OCc1c(OC)ccc(F)c1F)-n1c(=O)[nH]c2csc(C(O)=O)c2c1=O
Molecular Formula
C22H15F3N2O7S
Molecular Weight
508.42
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Alternative Products

CatalogName
BUP02769-01Linzagolix
M34100-01Linzagolix choline
HY-120767Linzagolix (choline)
RM-L230003-01Linzagolix Impurity 3
RM-L230002-01Linzagolix Impurity 2
RM-L230006-01Linzagolix Impurity 6
RM-L230004-01Linzagolix Impurity 4
RM-L230001-01Linzagolix Impurity 1
RM-L230005-01Linzagolix Impurity 5

Popular Products